Cargando…

A novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair

BACKGROUND: Here, we describe the design and characterization of a novel, cryopreserved, viable osteochondral allograft (CVOCA), along with evidence that the CVOCA can improve outcomes of marrow stimulation for articular cartilage repair. METHODS: Histological staining was performed to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Geraghty, Sandra, Kuang, Jin-Qiang, Yoo, Dana, LeRoux-Williams, Michelle, Vangsness, C. Thomas, Danilkovitch, Alla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436093/
https://www.ncbi.nlm.nih.gov/pubmed/25968127
http://dx.doi.org/10.1186/s13018-015-0209-5
_version_ 1782372003447046144
author Geraghty, Sandra
Kuang, Jin-Qiang
Yoo, Dana
LeRoux-Williams, Michelle
Vangsness, C. Thomas
Danilkovitch, Alla
author_facet Geraghty, Sandra
Kuang, Jin-Qiang
Yoo, Dana
LeRoux-Williams, Michelle
Vangsness, C. Thomas
Danilkovitch, Alla
author_sort Geraghty, Sandra
collection PubMed
description BACKGROUND: Here, we describe the design and characterization of a novel, cryopreserved, viable osteochondral allograft (CVOCA), along with evidence that the CVOCA can improve outcomes of marrow stimulation for articular cartilage repair. METHODS: Histological staining was performed to evaluate the CVOCA tissue architecture. CVOCAs were tested for the presence of extracellular matrix (ECM) proteins and chondrogenic growth factors using ELISA. Cell viability and composition were examined via live/dead staining, fluorescence-activated cell sorting (FACS) analysis, and immunofluorescence staining. FACS analysis and a TNF-α secretion bioassay were used to confirm the lack of immunogenic cells. Effects of the CVOCA on mesenchymal stem cells (MSCs) were tested using in vitro migration and chondrogenesis assays. The ability of the CVOCA to augment marrow stimulation in vivo was evaluated in a goat model. RESULTS: A method of tissue processing and preservation was developed resulting in a CVOCA with pores and minimal bone. The pores were found to increase the flexibility of the CVOCA and enhance growth factor release. Histological staining revealed that all three zones of hyaline cartilage were preserved within the CVOCA. Chondrogenic growth factors (TGF-β1, TGF-β3, BMP-2, BMP-4, BMP-7, bFGF, IGF-1) and ECM proteins (type II collagen, hyaluronan) were retained within the CVOCA, and their sustained release in culture was observed (TGF β1, TGF-β2, aggrecan). The cells within the CVOCA were confirmed to be chondrocytes and remained viable and functional post-thaw. Immunogenicity testing confirmed the absence of immunogenic cells. The CVOCA induced MSC migration and chondrogenesis in vitro. Experimental results using devitalized flash frozen osteochondral allografts revealed the importance of preserving all components of articular cartilage in the CVOCA. Goats treated with the CVOCA and marrow stimulation exhibited better repair compared to goats treated with marrow stimulation alone. CONCLUSIONS: The CVOCA retains viable chondrocytes, chondrogenic growth factors, and ECM proteins within the intact architecture of native hyaline cartilage. The CVOCA promotes MSC migration and chondrogenesis following marrow stimulation, improving articular cartilage repair.
format Online
Article
Text
id pubmed-4436093
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44360932015-05-20 A novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair Geraghty, Sandra Kuang, Jin-Qiang Yoo, Dana LeRoux-Williams, Michelle Vangsness, C. Thomas Danilkovitch, Alla J Orthop Surg Res Research Article BACKGROUND: Here, we describe the design and characterization of a novel, cryopreserved, viable osteochondral allograft (CVOCA), along with evidence that the CVOCA can improve outcomes of marrow stimulation for articular cartilage repair. METHODS: Histological staining was performed to evaluate the CVOCA tissue architecture. CVOCAs were tested for the presence of extracellular matrix (ECM) proteins and chondrogenic growth factors using ELISA. Cell viability and composition were examined via live/dead staining, fluorescence-activated cell sorting (FACS) analysis, and immunofluorescence staining. FACS analysis and a TNF-α secretion bioassay were used to confirm the lack of immunogenic cells. Effects of the CVOCA on mesenchymal stem cells (MSCs) were tested using in vitro migration and chondrogenesis assays. The ability of the CVOCA to augment marrow stimulation in vivo was evaluated in a goat model. RESULTS: A method of tissue processing and preservation was developed resulting in a CVOCA with pores and minimal bone. The pores were found to increase the flexibility of the CVOCA and enhance growth factor release. Histological staining revealed that all three zones of hyaline cartilage were preserved within the CVOCA. Chondrogenic growth factors (TGF-β1, TGF-β3, BMP-2, BMP-4, BMP-7, bFGF, IGF-1) and ECM proteins (type II collagen, hyaluronan) were retained within the CVOCA, and their sustained release in culture was observed (TGF β1, TGF-β2, aggrecan). The cells within the CVOCA were confirmed to be chondrocytes and remained viable and functional post-thaw. Immunogenicity testing confirmed the absence of immunogenic cells. The CVOCA induced MSC migration and chondrogenesis in vitro. Experimental results using devitalized flash frozen osteochondral allografts revealed the importance of preserving all components of articular cartilage in the CVOCA. Goats treated with the CVOCA and marrow stimulation exhibited better repair compared to goats treated with marrow stimulation alone. CONCLUSIONS: The CVOCA retains viable chondrocytes, chondrogenic growth factors, and ECM proteins within the intact architecture of native hyaline cartilage. The CVOCA promotes MSC migration and chondrogenesis following marrow stimulation, improving articular cartilage repair. BioMed Central 2015-05-14 /pmc/articles/PMC4436093/ /pubmed/25968127 http://dx.doi.org/10.1186/s13018-015-0209-5 Text en © Geraghty et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Geraghty, Sandra
Kuang, Jin-Qiang
Yoo, Dana
LeRoux-Williams, Michelle
Vangsness, C. Thomas
Danilkovitch, Alla
A novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair
title A novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair
title_full A novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair
title_fullStr A novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair
title_full_unstemmed A novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair
title_short A novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair
title_sort novel, cryopreserved, viable osteochondral allograft designed to augment marrow stimulation for articular cartilage repair
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436093/
https://www.ncbi.nlm.nih.gov/pubmed/25968127
http://dx.doi.org/10.1186/s13018-015-0209-5
work_keys_str_mv AT geraghtysandra anovelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT kuangjinqiang anovelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT yoodana anovelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT lerouxwilliamsmichelle anovelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT vangsnesscthomas anovelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT danilkovitchalla anovelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT geraghtysandra novelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT kuangjinqiang novelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT yoodana novelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT lerouxwilliamsmichelle novelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT vangsnesscthomas novelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair
AT danilkovitchalla novelcryopreservedviableosteochondralallograftdesignedtoaugmentmarrowstimulationforarticularcartilagerepair